Results 221 to 230 of about 423,879 (287)
Correction to: Non-adherence to urate lowering therapy in gout after 5 years is related to poor outcomes: results from the NOR-Gout study. [PDF]
Rheumatology (Oxford)europepmc +1 more source
Reduced creatinine clearance is associated with early development of subcutaneous tophi in people with gout [PDF]
core +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Update on emerging urate-lowering therapies
Current Opinion in Rheumatology, 2009To discuss currently available urate-lowering therapeutic options for gout in the United States and newer therapeutic initiatives in development.Currently available urate-lowering drugs include allopurinol and probenecid. These drugs are effective but are often underdosed or underutilized, and caution must be taken in patients with multiple ...
Saima, Chohan, Michael A, Becker
openaire +2 more sources
Cardiovascular Safety of Urate Lowering Therapies
Current Rheumatology Reports, 2019The effect of urate lowering treatment (ULT) on cardiovascular (CV) risk and mortality in gout has been a topic of interest. This review discusses the CV effect of ULT and comparative CV safety among ULT agents.The mechanism linking gout with CV risk is not fully understood but seems multifactorial involving hyperuricemia, xanthine oxidase (XO ...
Eun Ha, Kang, Seoyoung C, Kim
openaire +2 more sources